Syrian team patents locally developed device for cancer research

(Tehran Ana)- A Syrian research team has patented a locally developed photodynamic irradiation device for cancer treatment research.

New drug combinations show promise against liver cancer

(Tehran Ana)- A new study using patient-derived “mini-tumors” has identified promising drug combinations that could lead to more effective liver cancer treatments.

Powdered drug developed to prevent kidney stones in children

(Tehran Ana)- Iranian researchers have developed Citrulize-K, a powdered medication designed to prevent kidney stone formation in children by regulating the urinary environment and limiting crystal growth.

Hidden lung mechanism could lead to more effective flu vaccines

(Tehran Ana)- A new study has uncovered an unexpected role for immune cells in the lungs that could help pave the way for more effective influenza vaccines.

New drug nearly doubles survival in pancreatic cancer

(Tehran Ana)- U.S. health authorities have approved a new targeted drug that nearly doubles median survival for patients with metastatic pancreatic cancer compared with chemotherapy alone.

Experimental drug burns fat without suppressing appetite

(Tehran Ana)- An experimental compound helped obese mice burn more fat and lose weight without reducing food intake or muscle mass.

Vitamin B6 shows promise against depression

(Tehran Ana)- A new study from the University of Reading suggests that high-dose vitamin B6 may significantly reduce depressive symptoms, offering a potential new avenue for supporting mental health.

Diet and fasting improve Diabetes in women

(Tehran Ana)- An Indian study found that a plant-based diet and 14-hour fasting improved blood sugar and weight in women with type 2 diabetes.

New discovery could help diagnose Parkinson’s years before symptoms appear

(Tehran Ana)- A new study suggests that changes in odor perception could help diagnose Parkinson’s disease years before motor symptoms emerge.

Next-generation cancer drugs move toward clinical use

(Tehran Ana)- Bispecific antibodies are rapidly entering cancer treatment, while researchers are developing more advanced multispecific versions that target three or more molecules at once.
بعدی 1 2 3 4 5 قبلی